Benha University Hospitals - Otolaryngology department
Banhā, Qalyobia, 6460001, Egypt
NCT Number: NCT06858423
Budesonide is a medication of the corticosteroid type. Available as an inhaler, nebulization solution, The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease is used for allergic rhinitis and nasal polyps fluticasone propionate
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 4
Banhā, Qalyobia, 6460001, Egypt
The current study aims to compare between results of budesonid nasal irrigation and fluticasone nasal spray in the treatment of adult patients with Allergic Rhinitis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
120 patients received budesonide buffered with 0.9% isotonic saline.
120 patients received fluticasone propionate nasal spray.
120 patients used 0.9% saline for nasal irrigation.
Time frame: 1 month
improvement measured by pre- and post-treatment SNOT score
Time frame: 1 month
by comparing pre and post treatment lund*Mackay score
Time frame: 1 month
Monitoring of pre and post treatment measurements of e morning serum cortisol level
Benha University
Other
Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in the Treatment of Adult Patients With Allergic Rhinitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05301647
Allergy Pollen, Child, Only
Naples, Italy
View Trial DetailsNCT01925729
Hypersensitivity, Immune System Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT03039101
Hypersensitivity, Immune System Diseases
Columbus, Ohio, United States
View Trial DetailsNCT03075917
Allergic Rhinitis, Hypersensitivity
Bagnols-sur-Cèze, France
View Trial Details